These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32211521)

  • 1. Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis.
    Ishii A; Yokoyama M; Tsuji H; Fujii Y; Tamaoka A
    eNeurologicalSci; 2020 Jun; 19():100236. PubMed ID: 32211521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma.
    Hayakawa N; Kikuchi E; Suzuki S; Oya M
    Int Cancer Conf J; 2020 Jul; 9(3):123-126. PubMed ID: 32582515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report.
    Takai M; Kato D; Iinuma K; Maekawa YM; Nakane K; Tsuchiya T; Yokoi S; Koie T
    Urol Case Rep; 2020 Jul; 31():101145. PubMed ID: 32190548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Metastatic Ureteral Cancer Treated with Pembrolizumab without Relapse of Ocular Myasthenia Gravis].
    Hara S; Honda M; Kawaharada A; Nakazono M; Onuma H; Yamada H; Kiyota H; Egawa S
    Hinyokika Kiyo; 2022 Dec; 68(12):377-383. PubMed ID: 36627771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel uses of complement inhibitors in myasthenia gravis-Two case reports.
    Zadeh S; Price H; Drews R; Bouffard MA; Young LH; Narayanaswami P
    Muscle Nerve; 2024 Mar; 69(3):368-372. PubMed ID: 38205840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Checkpoint inhibitor-induced myocarditis and myasthenia gravis in a recurrent/metastatic thymic carcinoma patient: a case report.
    Szuchan C; Elson L; Alley E; Leung K; Camargo AL; Elimimian E; Nahleh Z; Sadler D
    Eur Heart J Case Rep; 2020 Jun; 4(3):1-8. PubMed ID: 32617460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Re-Administration of Pembrolizumab for Urothelial Carcinoma after immune-Related Myasthenia Gravis : A Case Report].
    Kurokawa M; Shimizu K; Kitabayashi R; Ogawa K; Okada Y; Kubo K; Yamaguchi D; Okubo K
    Hinyokika Kiyo; 2022 Sep; 68(9):295-300. PubMed ID: 36199208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pembrolizumab-induced myasthenia gravis: A fatal case report.
    March KL; Samarin MJ; Sodhi A; Owens RE
    J Oncol Pharm Pract; 2018 Mar; 24(2):146-149. PubMed ID: 28147928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab-Induced Myasthenia Gravis and Peripheral Neuropathy: A Case Series.
    McCormack SM; Hamad A
    Cureus; 2023 Sep; 15(9):e44799. PubMed ID: 37809208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.
    Saruwatari K; Sato R; Nakane S; Sakata S; Takamatsu K; Jodai T; Mito R; Horio Y; Saeki S; Tomita Y; Sakagami T
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30682845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab.
    Lau KH; Kumar A; Yang IH; Nowak RJ
    Muscle Nerve; 2016 Jun; 54(1):157-61. PubMed ID: 27065302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Pembrolizumab-Induced Myasthenia Gravis.
    Kosick TI; Patel K; Jasinski J; Dada B
    Cureus; 2023 Sep; 15(9):e45455. PubMed ID: 37859893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report.
    Tian CY; Ou YH; Chang SL; Lin CM
    J Med Case Rep; 2021 Apr; 15(1):244. PubMed ID: 33926558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia Gravis Associated With Programmed Death-1 (PD-1) Receptor Inhibitor Pembrolizumab: A 40-day Case Report.
    Ziobro AS; LaPlante RL; DeMari SR; Clark LM; Kingsley DJ; Smith AJ
    J Pharm Pract; 2021 Feb; 34(1):166-170. PubMed ID: 33143531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer.
    Todo M; Kaneko G; Shirotake S; Shimada Y; Nakano S; Okabe T; Ishikawa S; Oyama M; Nishimoto K
    IJU Case Rep; 2020 Jan; 3(1):17-20. PubMed ID: 32743459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors.
    Schwab A; Assaad M; Hamadi R; Zurndorfer J; Abi Melhem R; Holtzbach J; Loeffler J; Ibrahim M
    J Med Cases; 2022 Nov; 13(11):530-535. PubMed ID: 36506763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
    Zaremba A; Chorti E; Jockenhöfer F; Bolz S; Sirin S; Glas M; Becker JC; Ugurel S; Roesch A; Schadendorf D; Livingstone E; Hagenacker T; Zimmer L
    J Immunother Cancer; 2019 May; 7(1):141. PubMed ID: 31142383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors.
    Heleno CT; Mustafa A; Gotera NA; Tesar A
    Cureus; 2021 Jul; 13(7):e16316. PubMed ID: 34277306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer.
    Shah D; Young K
    Cureus; 2023 Dec; 15(12):e49867. PubMed ID: 38169986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
    Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
    BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.